External Nasal Dilator Market Size & Share, by Application (Sleep Apnea Management, Athletic Performance, Nasal Congestion Relief); Product Type; Material; End user; Form - Global Supply & Demand Analysis, Growth Forecasts, Statistics Report 2025-2034

External Nasal Dilator Market - Regional Analysis

North America Market Insights

North America is predicted to account for the largest share of 38.7% in the global external nasal dilator market. The leadership of the region is attributed to the increasing prevalence of sleep apnea and the advanced healthcare infrastructure. The progressive upliftment in the region is further facilitated by the U.S., which accounts for 85.4% of demand, whereas Canada demonstrates growth owing to its public healthcare coverage. Besides, the region hosts a sustained demand for non-invasive respiratory solutions, thus positioning North America as a global leader in this landscape.

The U.S. dominates the regional external nasal dilator market on account of a strong reimbursement structure and regulatory support. The market in the country is growing at a 6.9% CAGR, where the Medicare spending surpassed 810.6 million in 2024, representing a 15.3% year-over-year growth with coverage offered to an estimated 12.6 million beneficiaries. Besides, the CDC study notes that there are over 40 million obstructive sleep apnea patients in the country, out of which 25.3% utilize nasal dilators. Furthermore, the National Institute of Health observed a 9.3% revenue growth owing to the expansion of virtual sleep clinics.

The external nasal dilator market in Canada is shaped by substantial allocations towards the healthcare sector. Ontario is the major contributor to the country’s market, which expanded its coverage by a remarkable 18.5% since 2021, offering benefits to over 200,000 yearly patients.  Besides, Health Canada stated that its 2023 guidelines significantly reduced approval timelines by 32.4% attracting more players to operate in this field. Quebec offers tax incentives that accelerate domestic production with a 12.4% year-over-year demand owing to the presence of rising aging demographics, according to the Canadian Institute for Health Information.

APAC Market Insights

The Asia Pacific external nasal dilator market is anticipated to record the fastest growth from 2025 to 2034. The increasing prevalence of sleep apnea and healthcare modernization are the key factors propelling growth in the region’s landscape. China is retaining its dominance in the regional dynamics, followed by Japan and India. As evidence, MHLW denotes that it allocated 12.5% of its healthcare budget to external nasal dilators with a high priority on elderly care. Similarly, South Korea leads in terms of digital health integration, leveraging more than 20 FDA-approved exclusive devices, whereas Malaysia contributes to this growth with the presence of an expanded patient pool.

China is maintaining a strong leadership over the Asia Pacific’s external nasal dilator market. The country's augmentation in this sector is highly supported by massive government investments and a large group of assorted population. In this regard, NMPA stated that it allocated USD 1.3 billion for sleep disorder devices, which includes bulk procurement in the public hospitals. In addition, the World Health Organization stated that the country has 80.5 million obstructive sleep apnea patients and 70.5% domestic production capabilities, indicating a prolific opportunity for the players to operate in the country’s market.

The external nasal dilator market in India is expanding remarkably due to supportive government policies and telemedicine partnerships. In this regard, the Ayushman Bharat Scheme invested USD 510.6 million to provide affordable external nasal dilators to an estimated 50.6 million underdiagnosed obstructive sleep apnea patients. Besides, NITI Aayog in 2024 reported that the telemedicine collaborations successfully enhanced the rural access by 25.4% whereas the Make in India subsidies reduced production costs by 25.6%. Furthermore, 92% of demand in the country originates from sub-$3 products.

Country-wise Government Provinces

Europe Market Insights

The external nasal dilator market in Europe is propagating at a notable pace, with the potential to maintain its position as the 2nd largest shareholder. This is supported by the presence of prominent countries and their strong potential in this sector. Germany and the U.K. lead in this landscape with the ever-increasing obstructive sleep apnea prevalence and robust reimbursement policies. On the other hand, in the EU, the Medical Device Regulation in 2024 successfully streamlined approvals, reducing the approval timelines by 32.6%. In addition, telemedicine integration and eco-material innovations further propel growth in this region.

Germany dominates Europe’s external nasal dilator market with a 32.2% revenue share, prompted by its huge healthcare spending. Exemplifying the same, BMG in 2024 stated that the country’s healthcare spending surpassed €4.7 billion on sleep therapy. Whereas the country offers 90% of public healthcare coverage for prescribed devices, and the demand grows at 15.3% reinforcing its captivity in this sector. Moreover, the domestic manufacturers such as Löwenstein Medical are investing €210.7 million in smart dilators with integrated sleep tracking, thus allowing greater business flow.

The UK holds a 28.4% revenue share of the Europe external nasal dilator market, supported by its National Health Service 2025 mandate to screen the afflicted individuals. In this regard, the ABPI report published in 2024 stated that its NICE guidelines currently recommend external nasal dilators as the first-line therapy in terms of acute obstructive sleep apnea, in turn creating a 22.45% increased demand in prescriptions. Besides, the country’s government allocated £206.8 million from its Innovation Fund to develop next-generation dilators, hence consolidating the nation’s role as a key player in the region.

Government Investments, Policies & Funding